Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

COVID-19 Mid-term Impact on Hepatocellular Carcinoma in Patients With Hepatitis C Chronic Infection

SILVIU GULER-MARGARITIS, ADRIANA MERCAN-STANCIU, LETITIA TOMA, DANIEL RUSIE, TEODORA ISAC, MIHAI DODOT, ANCA ZGURA, NICOLAE BACALBASA, BOGDAN HAINEALA, DUMITRU CRISTINEL BADIU, DRAGOS SERBAN and ELENA LAURA ILIESCU
In Vivo November 2021, 35 (6) 3377-3383; DOI: https://doi.org/10.21873/invivo.12636
SILVIU GULER-MARGARITIS
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
2Department of Urology, Fundeni Clinical Institute, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ADRIANA MERCAN-STANCIU
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
3Department of Internal Medicine II, Fundeni Clinical Institute, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LETITIA TOMA
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
3Department of Internal Medicine II, Fundeni Clinical Institute, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DANIEL RUSIE
4Department of General Surgery, Clinical Emergency Hospital, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TEODORA ISAC
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
3Department of Internal Medicine II, Fundeni Clinical Institute, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MIHAI DODOT
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
3Department of Internal Medicine II, Fundeni Clinical Institute, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANCA ZGURA
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
5Department of Oncology-Radiotherapy, “Prof Dr Alexandru Trestioreanu” Institute of Oncology, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NICOLAE BACALBASA
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BOGDAN HAINEALA
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
2Department of Urology, Fundeni Clinical Institute, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DUMITRU CRISTINEL BADIU
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
6General Surgery Department, Bagdasar Arseni Clinical Emergency Hospital, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: doctorcristianbadiu{at}yahoo.com
DRAGOS SERBAN
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
7Department of Surgery, University Emergency Hospital, Bucharest, Romania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELENA LAURA ILIESCU
1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
3Department of Internal Medicine II, Fundeni Clinical Institute, Bucharest, Romania;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 35 no. 6 3377-3383
DOI 
https://doi.org/10.21873/invivo.12636
PMID 
34697172

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received July 18, 2021
  • Revision received August 20, 2021
  • Accepted August 23, 2021
  • Published online October 25, 2021.

Copyright & License 
Copyright © 2021 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. SILVIU GULER-MARGARITIS1,2,
  2. ADRIANA MERCAN-STANCIU1,3,
  3. LETITIA TOMA1,3,
  4. DANIEL RUSIE4,
  5. TEODORA ISAC1,3,
  6. MIHAI DODOT1,3,
  7. ANCA ZGURA1,5,
  8. NICOLAE BACALBASA1,
  9. BOGDAN HAINEALA1,2,
  10. DUMITRU CRISTINEL BADIU1,6⇑,
  11. DRAGOS SERBAN1,7 and
  12. ELENA LAURA ILIESCU1,3
  1. 1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania;
  2. 2Department of Urology, Fundeni Clinical Institute, Bucharest, Romania;
  3. 3Department of Internal Medicine II, Fundeni Clinical Institute, Bucharest, Romania;
  4. 4Department of General Surgery, Clinical Emergency Hospital, Bucharest, Romania;
  5. 5Department of Oncology-Radiotherapy, “Prof Dr Alexandru Trestioreanu” Institute of Oncology, Bucharest, Romania;
  6. 6General Surgery Department, Bagdasar Arseni Clinical Emergency Hospital, Bucharest, Romania;
  7. 7Department of Surgery, University Emergency Hospital, Bucharest, Romania
  1. Correspondence to: Dumitru-Cristinel Badiu, “Carol Davila” University of Medicine and Pharmacy, 37 Dionisie Lupu Street, District 2, 020021 Bucharest, Romania. E-mail: doctorcristianbadiu{at}yahoo.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • 4 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

In Vivo
Vol. 35, Issue 6
November-December 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 Mid-term Impact on Hepatocellular Carcinoma in Patients With Hepatitis C Chronic Infection
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
COVID-19 Mid-term Impact on Hepatocellular Carcinoma in Patients With Hepatitis C Chronic Infection
SILVIU GULER-MARGARITIS, ADRIANA MERCAN-STANCIU, LETITIA TOMA, DANIEL RUSIE, TEODORA ISAC, MIHAI DODOT, ANCA ZGURA, NICOLAE BACALBASA, BOGDAN HAINEALA, DUMITRU CRISTINEL BADIU, DRAGOS SERBAN, ELENA LAURA ILIESCU
In Vivo Nov 2021, 35 (6) 3377-3383; DOI: 10.21873/invivo.12636

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
COVID-19 Mid-term Impact on Hepatocellular Carcinoma in Patients With Hepatitis C Chronic Infection
SILVIU GULER-MARGARITIS, ADRIANA MERCAN-STANCIU, LETITIA TOMA, DANIEL RUSIE, TEODORA ISAC, MIHAI DODOT, ANCA ZGURA, NICOLAE BACALBASA, BOGDAN HAINEALA, DUMITRU CRISTINEL BADIU, DRAGOS SERBAN, ELENA LAURA ILIESCU
In Vivo Nov 2021, 35 (6) 3377-3383; DOI: 10.21873/invivo.12636
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Risk Factors and Clinical Significance of Grade ≥3 Neutropenia During the First Cycle of Cabazitaxel Therapy With Primary Pegfilgrastim Prophylaxis in Metastatic Castration-resistant Prostate Cancer
  • Impact of Donor Cirrhosis Outcome Risk Estimator (CORE) Score on Recipient Outcomes Following Living-donor Liver Transplantation
  • The Clinical Impact of Textbook Outcome in Patients With Stage 1 Gastric Cancer Who Received Laparoscopy-assisted Gastrectomy or Robotic-assisted Gastrectomy
Show more Clinical Studies

Keywords

  • COVID-19
  • direct-acting antivirals
  • hepatocellular carcinoma
  • hepatitis C virus infection
  • SARS-CoV-2
In Vivo

© 2026 In Vivo

Powered by HighWire